Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT (Journal of Clinical Immunology, (2019), 39, 7, (653-667), 10.1007/s10875-019-00659-8)

submitted on behalf of the Primary Immune Deficiency Treatment Consortium

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article unfortunately contained the missing author, Caridad Martinez. The authors would like to correct the list. We apologize for any inconvenience that this may have caused. The correct author list is shown above.

Original languageEnglish (US)
Pages (from-to)1211-1213
Number of pages3
JournalJournal of Clinical Immunology
Volume40
Issue number8
DOIs
StatePublished - Nov 1 2020
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT (Journal of Clinical Immunology, (2019), 39, 7, (653-667), 10.1007/s10875-019-00659-8)'. Together they form a unique fingerprint.

Cite this